CXCL13 and neoplasm: The identification of a TIGIT+PD-1+CXCL13+ CD8+ T cell subset—characterized by features of both function and tumor reactivity—highlights a critical population shaped by chronic antigen exposure and enriched particularly in MSI CRC patients.